Target intelligence / Profile preview

Outer capsid glycoprotein VP7, G4 genotype (Rotavirus VP7 G4) (VP7 G4)

Target
VP7 G4
Molecular classification
Viral glycoprotein, Calcium-binding protein, Structural protein, Immunogenic antigen
01

Overview

Rotavirus VP7 G4 is the outer capsid glycoprotein of rotavirus genotype G4, organized as calcium-stabilized trimers that form the outermost layer of the rotavirus triple-layered particle (TLP)[1][2]. The protein consists of two domains: a Rossmann-fold domain (domain I) and a jelly-roll beta sandwich domain (domain II), connected by disordered N- and C-terminal arms[1]. VP7 is stabilized through calcium ion binding at subunit interfaces, with the N-terminal arms gripping the underlying VP6 trimer layer[1][2]. VP7 G4 serves as a principal target of protective neutralizing antibodies and is immunodominant in rotavirus infections and vaccination[1][3]. The protein contains two critical antigenic epitopes: region 7-1 (comprising subunits 7-1a and 7-1b) and region 7-2, located on the outward-facing surface of the trimer[1][3]. Neutralizing antibodies inhibit rotavirus infection by binding to these epitopes and stabilizing the VP7 trimer, thereby preventing the calcium-dependent uncoating process necessary for viral entry[1]. The VP7 G4 layer is structurally the stiffest and most elastic component of the rotavirus particle, with strong resistance to fatigue and high breaking force[2]. Circulating G4 rotavirus strains show substantial antigenic variation compared to vaccine strains, particularly in the 7-1b epitope region, with multiple amino acid differences and potential escape mutations that may reduce vaccine effectiveness[3]. This antigenic variation is a significant challenge for rotavirus vaccine development and strain surveillance programs.

Other names
Viral protein 7Rotavirus glycoprotein G4G4 rotavirus VP7Outer capsid protein VP7
02

Mechanism of action

Neutralizing antibodies bind to VP7 trimeric structure at the intersubunit junction (region 7-1), stabilizing the trimer and inhibiting the uncoating trigger required for VP4 rearrangement and membrane penetration. Calcium withdrawal destabilizes VP7 trimers, initiating uncoating and viral entry.

03

Biological functions

Viral attachment and entry mediation (in conjunction with VP4)Calcium-dependent structural stabilizationCell receptor interactionViral particle assembly and maturationImmune evasion through antigenic variation
04

Disease associations

Infection (rotavirus infection)Gastroenteritis
05

Safety considerations

Antigenic drift and escape mutations in circulating G4 strains compared to vaccine strainsPotential for immune escape through mutations at neutralization epitopesVariable immunogenicity depending on glycosylation patterns at specific residues
06

Interacting drugs

Rotavirus vaccines (RotaTeq, Rotarix, Rotavac containing G4 strains)

1 more in the full profile.

07

Biomarkers

VP7 antigenic epitopes (7-1a, 7-1b, and 7-2) for strain identification and vaccine matchingAmino acid residues at positions 87-101 and 208-211 as G serotype signaturesNeutralizing antibody titers against VP7 for immunity assessment

Beyond the preview

Go deeper on Outer capsid glycoprotein VP7, G4 genotype (Rotavirus VP7 G4) (VP7 G4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Outer capsid glycoprotein VP7, G4 genotype (Rotavirus VP7 G4) (VP7 G4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call